$TBIO Translate Bio, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Translate Bio, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Translate Bio, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Translate Bio, Inc. for free.

CIK Number: 0001693415
IRS Number: 611807780
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: TBIO
Company Address: 29 HARTWELL AVENUE LEXINGTON 02421
Phone number: 617-945-7361
Former name: RaNA Therapeutics, Inc., date of change: 2016-12-28

Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidates include MRT5005 for the treatment of cystic fibrosis; and for the treatment of ornithine transcarbamylase deficiency. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA.

Translate Bio, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
BAUPOST GROUP LLC/MA10% Owner18,044,2390shares bought: 500,000 / shares sold: 0 BUYJun 30 202014 days ago
Beckman DaniellaDirector00Jun 17 202027 days ago
Demetri GeorgeDirector00Jun 16 202028 days ago
FORMELA JEAN FRANCOISDirector3,922,0100shares bought: 3,832,010 / shares sold: 0 BUYJun 17 202027 days ago
Hughes OwenDirector00Jun 16 202028 days ago
LYNCH DANIELDirector00Jun 17 202027 days ago
Meyer Robert J.Director00Jun 16 202028 days ago
Plenge Robert MDirector00Jun 16 202028 days ago
Shire Human Genetic Therapies, Inc.10% Owner00shares bought: 367,238 / shares sold: -7,078,945 STRONG SELLJun 30 202014 days ago

View all Translate Bio, Inc. insiders.

Translate Bio, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 30 2020TBIOTranslate Bio, Inc ...Shire Human Genetic Therapies, ...10% OwnerSellS20.686,824,992141,140,83506.8 M to 0 (-100.00 %)
Jun 30 2020TBIOTranslate Bio, Inc ...BAUPOST GROUP LLC/MA10% OwnerBuyP22.00500,00011,000,00018,044,23917.5 M to 18 M (+2.85 %)
Jun 17 2020TBIOTranslate Bio, Inc ...LYNCH DANIELDirectorOption ExerciseA15.3318,900289,73718,900
Jun 17 2020TBIOTranslate Bio, Inc ...Beckman DaniellaDirectorOption ExerciseA15.3318,900289,73718,900
Jun 17 2020TBIOTranslate Bio, Inc ...FORMELA JEAN FRANCOISDirectorOption ExerciseA15.3318,900289,73718,900
Jun 16 2020TBIOTranslate Bio, Inc ...Plenge Robert MDirectorOption ExerciseA15.3318,900289,73718,900
Jun 16 2020TBIOTranslate Bio, Inc ...Meyer Robert J.DirectorOption ExerciseA15.3318,900289,73718,900
Jun 16 2020TBIOTranslate Bio, Inc ...Hughes OwenDirectorOption ExerciseA15.3318,900289,73718,900
Jun 16 2020TBIOTranslate Bio, Inc ...Demetri GeorgeDirectorOption ExerciseA15.3318,900289,73718,900
Jun 05 2020TBIOTranslate Bio, Inc ...Shire Human Genetic Therapies, ...10% OwnerSellS19.7540,086791,6996,824,9926.9 M to 6.8 M (-0.58 %)
Jun 03 2020TBIOTranslate Bio, Inc ...Shire Human Genetic Therapies, ...10% OwnerSellS20.025,006100,2206,865,0786.9 M to 6.9 M (-0.07 %)
Jun 03 2020TBIOTranslate Bio, Inc ...Shire Human Genetic Therapies, ...10% OwnerSellS19.75100,3891,982,6836,870,0847 M to 6.9 M (-1.44 %)
Jun 03 2020TBIOTranslate Bio, Inc ...Shire Human Genetic Therapies, ...10% OwnerSellS20.531,40028,7426,970,4737 M to 7 M (-0.02 %)
Jun 03 2020TBIOTranslate Bio, Inc ...Shire Human Genetic Therapies, ...10% OwnerSellS19.85107,0722,125,3796,971,8737.1 M to 7 M (-1.51 %)
Mar 05 2020TBIOTranslate Bio, Inc ...Wooster RichardChief Scientific Of ...Option ExerciseA7.66150,0001,149,000150,000

View all Translate Bio, Inc. insider transactions.